Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses

NCT03041038 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03041038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03041038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2016
Completion date
August 31, 2020
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive congenital ichthyosis, congenital ichthyosiform erythroderma, epidermolytic ichthyosis, ichthyosis, lamellar ichthyosis, netherton syndrome